Allspring Global Investments Holdings LLC Has $84.94 Million Stock Position in HealthEquity, Inc. (NASDAQ:HQY)

Allspring Global Investments Holdings LLC lowered its holdings in HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 7.5% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,037,780 shares of the company's stock after selling 84,277 shares during the quarter. Allspring Global Investments Holdings LLC owned 1.19% of HealthEquity worth $84,942,000 at the end of the most recent quarter.

Other hedge funds have also recently added to or reduced their stakes in the company. International Assets Investment Management LLC bought a new position in shares of HealthEquity during the second quarter valued at $35,000. Paladin Wealth LLC bought a new position in HealthEquity during the 3rd quarter valued at about $39,000. Fidelis Capital Partners LLC acquired a new position in HealthEquity in the first quarter valued at about $42,000. GAMMA Investing LLC grew its stake in HealthEquity by 114.8% during the second quarter. GAMMA Investing LLC now owns 595 shares of the company's stock worth $51,000 after buying an additional 318 shares during the last quarter. Finally, Point72 Asia Singapore Pte. Ltd. acquired a new stake in shares of HealthEquity during the second quarter worth approximately $73,000. Institutional investors and hedge funds own 99.55% of the company's stock.

HealthEquity Trading Up 0.1 %

Shares of NASDAQ:HQY traded up $0.06 during trading on Monday, hitting $87.74. 366,549 shares of the company's stock were exchanged, compared to its average volume of 614,513. The company has a current ratio of 4.10, a quick ratio of 4.10 and a debt-to-equity ratio of 0.51. The firm has a market cap of $7.63 billion, a P/E ratio of 95.37, a PEG ratio of 1.31 and a beta of 0.52. The firm has a 50-day moving average price of $78.75 and a two-hundred day moving average price of $79.44. HealthEquity, Inc. has a 1-year low of $61.81 and a 1-year high of $89.23.

HealthEquity (NASDAQ:HQY - Get Free Report) last released its earnings results on Tuesday, September 3rd. The company reported $0.66 EPS for the quarter, topping analysts' consensus estimates of $0.50 by $0.16. The firm had revenue of $299.93 million during the quarter, compared to analyst estimates of $284.48 million. HealthEquity had a net margin of 9.61% and a return on equity of 9.01%. Equities analysts predict that HealthEquity, Inc. will post 2.27 earnings per share for the current year.

Insider Activity at HealthEquity

In related news, Vice Chairman Stephen Neeleman sold 35,000 shares of the stock in a transaction that occurred on Thursday, July 25th. The shares were sold at an average price of $79.86, for a total value of $2,795,100.00. Following the sale, the insider now directly owns 89,769 shares in the company, valued at $7,168,952.34. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. In other news, Vice Chairman Stephen Neeleman sold 35,000 shares of the business's stock in a transaction on Thursday, July 25th. The shares were sold at an average price of $79.86, for a total value of $2,795,100.00. Following the completion of the transaction, the insider now owns 89,769 shares of the company's stock, valued at $7,168,952.34. The trade was a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Robert W. Selander sold 8,250 shares of the firm's stock in a transaction on Wednesday, October 9th. The stock was sold at an average price of $82.98, for a total value of $684,585.00. Following the sale, the director now directly owns 54,719 shares in the company, valued at $4,540,582.62. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders sold 44,497 shares of company stock worth $3,579,769. 2.20% of the stock is owned by insiders.

Wall Street Analyst Weigh In

Several research analysts have recently commented on HQY shares. Barrington Research reissued an "outperform" rating and issued a $105.00 target price on shares of HealthEquity in a report on Friday, September 20th. Deutsche Bank Aktiengesellschaft increased their target price on HealthEquity from $102.00 to $103.00 and gave the stock a "buy" rating in a report on Wednesday, September 4th. Bank of America lowered their target price on HealthEquity from $105.00 to $100.00 and set a "buy" rating for the company in a research note on Wednesday, September 4th. Royal Bank of Canada reiterated an "outperform" rating and set a $92.00 price target on shares of HealthEquity in a research report on Wednesday, September 4th. Finally, JMP Securities restated a "market outperform" rating and issued a $105.00 price objective on shares of HealthEquity in a research report on Wednesday, September 4th. Twelve research analysts have rated the stock with a buy rating, According to MarketBeat.com, the company has an average rating of "Buy" and a consensus target price of $103.83.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.